Dr. Rolf Kreutz was born in Berne, Switzerland. He obtained his medical degree from the University of Berne and trained in Internal Medicine in Langenthal and the University of Zurich in Switzerland before relocating to the United States in 2003. Dr. Rolf Kreutz joined the Johns Hopkins University/Sinai Program in Internal Medicine where he completed his residency training and worked under the mentorship of Dr. Paul Gurbel at the Sinai Center for Thrombosis Research. In 2006, Dr. Kreutz joined the Krannert Institute of Cardiology cardiovascular fellowship, where he also served as chief cardiology fellow. He underwent further subspecialty training in Interventional Cardiology before joining the Krannert Institute of Cardiology as assistant professor of clinical medicine.
Dr. Kreutz research interests include thrombosis, antiplatelet medications and 'personalized medicine'. He is studying the effect of variations in the human genome on in- vivo drug response through pharmacogenetic analyses. In addition, he is investigating the potential of drug-drug interactions to reduce the efficacy of antiplatelet drugs, in particular clopidogrel and statins.